Vera Therapeutics Inc. has announced the allocation of inducement awards to seventeen new employees under its Inducement Plan, as per Nasdaq Listing Rule 5635(c)(4). The awards, approved by the Compensation Committee on June 3, 2025, include non-qualified stock options for 124,000 shares of Class A common stock and restricted stock units (RSUs) for 65,925 shares. The stock options have an exercise price of $30.91, aligning with Vera's closing trading price on the grant date, and will vest over four years. The RSUs will also vest over four years, with specific vesting schedules outlined and contingent on continued employment with Vera.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。